HISTALIM joins Cerba HealthCare

HISTALIM joins Cerba HealthCare

We are pleased to announce that HISTALIM, a provider in histology, immunohistochemistry (IHC), in situ hybridization (ISH), and image analysis, has joined Barc Lab into the Cerba HealthCare group, allowing biopharmaceutical companies, Contract Research Organisations and Non-Governmental organisation easy access to a diversified portfolio of advanced diagnostic technologies and deep scientific expertise in biomarkers.

Learn more about HISTALIM by watching the video, or by exploring the website: www.histalim.com.

For more details, please click on the Announcement to read further.

 

 

Watch the interview with Jean-Philipp COTON, CEO of HISTALIM and learn about the added value HISTALIM brings to both Barc Lab and the Cerba HealthCare Group.